Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest episode artwork

EPISODE · Dec 22, 2025 · 7 MIN

Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest

from The Lancet Respiratory Medicine in conversation with · host The Lancet Group

Marion Moseby-Knappe talks about a prospective, international, observational biomarker study, within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial, to compare four markers of brain injury for the prediction of functional outcome in patients after cardiac arrest using assays that can be analysed on clinically available equipment. Click here to read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00363-7/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

Episode metadata supplied by the publisher feed · Published Dec 22, 2025

Embed this episode

NOW PLAYING

Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest

0:00 7:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Lancet Respiratory Medicine in conversation with?

This episode is 7 minutes long.

When was this The Lancet Respiratory Medicine in conversation with episode published?

This episode was published on December 22, 2025.

Can I download this The Lancet Respiratory Medicine in conversation with episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!